http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d874a5a80436cd8f5b26e0670e47c319
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cesaroni |
| name | Matteo Cesaroni |
| given-name | Matteo |
| organization-name | Fels Cancer Center, Temple University, Philadelphia, Pennsylvania, USA Fels Institute, Temple University School of Medicine, Philadelphia, PA 6 Precision Oncology, Sanofi R&D, 94400 Vitry-sur-Seine, France Fels Institute for Cancer and Molecular Biology, Temple University, Philadelphia, Pennsylvania, USA World Without Disease, Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania, USA 1Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania. ‡Janssen Research and Development, LLC, Spring House, PA 19477; and Lewis Katz School of Medicine at Temple University Philadelphia Pennsylvania Janssen Research & Development, LLC, Springhouse, PA, USA Authors' Affiliations: 1Department of Cancer Biology, The Scripps Research Institute, Jupiter; 2Molecular Oncology Program, DeWitt Daughtry Family Department of Surgery and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida; 3The Wistar Institute; 4Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine; 5Department of Cancer Biology, Abramson Family Cancer Research Institute; and 6Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and 7Ecole Polytechnique Fédérale de Lausanne, EPFL SV ISREC, Lausanne, Switzerland; Authors' Affiliations: 1Department of Cancer Biology, The Scripps Research Institute, Jupiter; 2Molecular Oncology Program, DeWitt Daughtry Family Department of Surgery and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida; 3The Wistar Institute; 4Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine; 5Department of Cancer Biology, Abramson Family Cancer Research Institute; and 6Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and 7Ecole Polytechnique Fédérale de Lausanne, EPFL SV ISREC, Lausanne, Switzerland 1Department of Experimental Oncology, European Institute of Oncology;; 2Institute of Molecular Oncology of the Italian Foundation for Cancer Research; The Wistar Institute, Philadelphia, Pennsylvania, USA Authors' Affiliations: 1Fels Institute for Cancer Research and Molecular Biology; and Janssen Research & Development, LLC Spring House Pennsylvania 1 Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, 2Cogentech, Consortium for Genomic Technologies, Via Adamello 16, 20139 Milano and 3IFOM, FIRC Institute of Molecular Oncology Foundation, Via Adamello 16, 20139 Milano, Italy |
Incoming Links
Total number of triples: 54.